Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.

Nozoe T, Mori E, Iguchi T, Ezaki T.

Int Surg. 2013 Oct-Dec;98(4):283-8. doi: 10.9738/INTSURG-D-12-00029.1.

PMID:
24229009
2.

Evaluation of histopathological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study.

Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Nanasawa T, Watanabe T.

Breast Cancer. 2000;7(3):201-9.

PMID:
11029799
3.

An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.

Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1380-91.

PMID:
23826420
4.

Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases.

Li S, Yu KD, Fan L, Hou YF, Shao ZM.

Ann Surg Oncol. 2011 Sep;18(9):2492-9. doi: 10.1245/s10434-011-1626-2.

PMID:
21360247
5.

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.

Wong H, Lau S, Leung R, Chiu J, Cheung P, Wong TT, Liang R, Epstein RJ, Yau T.

Med Oncol. 2012 Sep;29(3):1536-42. doi: 10.1007/s12032-011-0082-y.

PMID:
21983862
6.

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC.

Br J Cancer. 2014 Jul 8;111(1):157-65. doi: 10.1038/bjc.2014.279.

PMID:
24874480
7.

[Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].

Guan Y, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):196-9. Chinese.

PMID:
18756935
9.

Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.

Cyr A, Gao F, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Ann Surg Oncol. 2012 Oct;19(10):3185-91. doi: 10.1245/s10434-012-2547-4.

PMID:
22890591
10.

High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.

Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q.

Med Oncol. 2013 Mar;30(1):475. doi: 10.1007/s12032-013-0475-1.

PMID:
23371253
11.

[Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients].

Liu ZB, Wu J, Ping B, Feng LQ, Shen ZZ, Shao ZM.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):610-4. Chinese.

PMID:
19102940
12.

p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.

de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J.

J Surg Res. 2007 Jun 1;140(1):109-14.

PMID:
17291532
13.

[Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].

Modesto A, Gandy C, Mery E, Filleron T, Massabeau C, Izar F, Charitansky H, Roché H, de Lafontan B.

Cancer Radiother. 2014 Mar;18(2):107-10. doi: 10.1016/j.canrad.2013.12.007. French.

PMID:
24637020
14.

The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.

Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, Su CC, Chen DR.

Breast. 2013 Oct;22(5):968-73. doi: 10.1016/j.breast.2013.05.010.

PMID:
23787124
15.

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Song Y, Liu X, Zhang G, Song H, Ren Y, He X, Wang Y, Zhang J, Zhang Y, Sun S, Liang X, Sun Q, Pang D.

World J Surg Oncol. 2013 Jun 6;11:129. doi: 10.1186/1477-7819-11-129.

PMID:
23738706
16.

[Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].

Zhang B, Liu FF, Ma YJ, Gu F.

Zhonghua Zhong Liu Za Zhi. 2013 Dec;35(12):904-9. Chinese.

PMID:
24506959
18.

Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse.

Kader HA, Jackson J, Mates D, Andersen S, Hayes M, Olivotto IA.

Breast J. 2001 Jan-Feb;7(1):8-13.

PMID:
11348409
19.

Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.

Kapoor NS, Shamonki J, Sim MS, Chung CT, Giuliano AE.

Ann Surg Oncol. 2013 Aug;20(8):2576-81. doi: 10.1245/s10434-013-2924-7.

PMID:
23468047
20.
Items per page

Supplemental Content

Support Center